Frans van Houten

Shez Partovi to succeed Jeroen Tas as Philips’ Chief Innovation & Strategy Officer

Retrieved on: 
Tuesday, March 2, 2021
Businesspeople, Jeroen Tas, Frans van Houten, Philips, Companies, Brands, Van Houten

Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Shez Partovi will join Philips Executive Committee, effective from March 22, 2021, in order to succeed Jeroen Tas as Chief Innovation & Strategy Officer, effective from July 1, 2021.

Key Points: 
  • Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Shez Partovi will join Philips Executive Committee, effective from March 22, 2021, in order to succeed Jeroen Tas as Chief Innovation & Strategy Officer, effective from July 1, 2021.
  • Mr. Partovi will report directly to CEO Frans van Houten and work closely with Mr. Tas to ensure a seamless transition.
  • Mr. Tas, who joined Philips in 2011 as Chief Information Officer and became Chief Innovation & Strategy Officer in 2017, has made a personal decision to assume a part-time position in Philips focused on continuation of the companys strategic business development until the end of 2022.
  • On behalf of Philips Executive Committee, I am very pleased to welcome Shez Partovi as our new Chief Innovation & Strategy Officer, said Frans van Houten, CEO of Royal Philips.

Philips again recognized as a Clarivate Top 100 Global Innovator

Retrieved on: 
Friday, February 26, 2021
Articles, Bibliometrics, Clarivate, Frans van Houten, Science and technology, Economy, Philips, Innovation

Our global R&D program and strong intellectual property portfolio continue to fuel our ability to truly impact global health challenges through innovation, said Frans van Houten, CEO of Royal Philips.

Key Points: 
  • Our global R&D program and strong intellectual property portfolio continue to fuel our ability to truly impact global health challenges through innovation, said Frans van Houten, CEO of Royal Philips.
  • I am very pleased that we have again been named as a Clarivate Top 100 Global Innovator, for the 8th consecutive year.
  • The Clarivate Top 100 Global Innovators 2021 come from three continents and 14 countries/regions.
  • [1] To compile its Clarivate Top 100 Global Innovators list, Clarivate tracks innovation based on four indicators: 1.

Philips presents its performance and value creation trajectory for the 2021-2025 period at its Capital Markets Day

Retrieved on: 
Friday, November 6, 2020
Companies, Eindhoven, Philips, Videotelephony, Frans van Houten, Brands, Industries, Abhijit, Companies, Eindhoven, Philips, Videotelephony, Frans van Houten, Brands, Industries, Abhijit

We have transformed Philips into a global health technology leader, applying our innovation strength to improve the health and well-being of people, said Frans van Houten, CEO of Royal Philips.

Key Points: 
  • We have transformed Philips into a global health technology leader, applying our innovation strength to improve the health and well-being of people, said Frans van Houten, CEO of Royal Philips.
  • The transformation has also led to a structurally improved growth and profitability profile of the company.
  • We plan to accelerate sales growth and improve the Adjusted EBITA margin to high-teens by 2025, said Abhijit Bhattacharya, CFO of Royal Philips.
  • Philips Capital Markets Day will start today at 13:00 CET / 12:00 GMT / 07:00 EST.

Philips responds to Congressional report

Retrieved on: 
Friday, July 31, 2020
Companies, Respiratory therapy, Eindhoven, Philips, Videotelephony, Frans van Houten, Industries, Ventilator, Manufactured goods

Philips is supporting healthcare providers in the U.S. and globally to combat the COVID-19 pandemic, said Frans van Houten, CEO of Royal Philips.

Key Points: 
  • Philips is supporting healthcare providers in the U.S. and globally to combat the COVID-19 pandemic, said Frans van Houten, CEO of Royal Philips.
  • We do not recognize the conclusions in the subcommittees report, and we believe that not all the information that we provided has been reflected in the report.
  • I would like to make clear that at no occasion, Philips has raised prices to benefit from the crisis situation.
  • Philips is producing and delivering this ventilator to HHS in line with the agreed delivery schedule.

Philips appoints Deeptha Khanna as Chief Business Leader of the Personal Health businesses and Edwin Paalvast as Chief of International Markets

Retrieved on: 
Thursday, July 16, 2020
Surname, Names, Companies, Eindhoven, Philips, Videotelephony, Frans van Houten, Van Houten, Khanna

Ms. Khanna and Mr. Paalvast will become members of Philips Executive Committee reporting to Philips CEO Frans van Houten.

Key Points: 
  • Ms. Khanna and Mr. Paalvast will become members of Philips Executive Committee reporting to Philips CEO Frans van Houten.
  • Ms. Khanna joins Philips from Johnson & Johnson to lead its Personal Health businesses that were temporarily led by Frans van Houten.
  • And in the personal health domain, we are seeing an accelerated shift in priorities and buying behaviors towards online.
  • Deeptha Khanna (India-born Singaporean, 1976) most recently was the global President of Johnson & Johnsons Skin Health business and Office of Marketing Value.

FDA lifts injunction on manufacture and distribution of Philips’ defibrillators in the US

Retrieved on: 
Friday, April 24, 2020
Companies, Eindhoven, Philips, Videotelephony, Health, Articles, Food and Drug Administration, Consent decree, Frans van Houten

This business has been operating under a consent decree with the FDA since November 2017.

Key Points: 
  • This business has been operating under a consent decree with the FDA since November 2017.
  • Under the terms of the consent decree, Philips was required to suspend manufacture and distribution of its defibrillators from specific Philips facilities in the U.S., pending FDA certification via inspection of the facilities compliance with Quality System Regulation.
  • Philips continues to comply with the terms of the consent decree, which remains in effect, and includes ongoing regulatory compliance monitoring and facility inspections of the ECR business and of Philips other patient care businesses by the FDA.
  • The injunction lift is an important milestone for Philips, as we have enhanced the regulatory compliance processes in our ECR business and throughout the company, said Frans van Houten, CEO of Royal Philips.

KLM and Philips to set up a special freight airlift from Amsterdam to China

Retrieved on: 
Thursday, April 9, 2020
Companies, Economy of the Netherlands, Air France–KLM, Eindhoven, Brands, Philips, Videotelephony, KLM, Frans van Houten

KLM has now joined forces with Royal Philips (NYSE: PHG; AEX: PHIA) and the Dutch government to create a temporary special cargo airlift between the Netherlands and China.

Key Points: 
  • KLM has now joined forces with Royal Philips (NYSE: PHG; AEX: PHIA) and the Dutch government to create a temporary special cargo airlift between the Netherlands and China.
  • Philips initiative to team up with KLM to find a solution for the pressing need for freight capacity between Europe and China for critical medical equipment and supplies fully underlines this.
  • Philips and KLM have been important partners for more than a hundred years, said Frans van Houten, CEO Royal Philips.
  • It is good that we have quickly found each other again in this time of need to make this important airlift to China possible.

Philips and the U.S. government collaborate in ventilator production ramp up to combat COVID-19 pandemic

Retrieved on: 
Wednesday, April 8, 2020
Respiratory therapy, Companies, Names, Eindhoven, Philips, Videotelephony, Frans van Houten, Medical ventilator, Van Houten, Brands

Philips will invest several tens of millions in its ventilator manufacturing sites in the U.S.

Key Points: 
  • Philips will invest several tens of millions in its ventilator manufacturing sites in the U.S.
    We are actively collaborating with the U.S. government to help save lives in the U.S. and across the globe, said Frans van Houten, CEO of Royal Philips.
  • There is an unprecedented global demand for medical equipment to help diagnose and treat patients with COVID-19.
  • We welcome the support of the U.S. government in our efforts to aggressively increase the production of hospital ventilators.
  • Philips may divide orders into batches to be delivered in phases, so that the company can simultaneously serve multiple countries/regions in need.

Statement of Philips CEO Frans van Houten on the COVID-19 outbreak

Retrieved on: 
Wednesday, March 18, 2020
Companies, Eindhoven, Names, Philips, Videotelephony, Frans van Houten, Brands, Van Houten

Amsterdam, the Netherlands Frans van Houten, CEO of Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today provided an update on how Philips is addressing the constantly evolving coronavirus disease (COVID-19) outbreak, as its epicenter is shifting from China to the West.

Key Points: 
  • Amsterdam, the Netherlands Frans van Houten, CEO of Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today provided an update on how Philips is addressing the constantly evolving coronavirus disease (COVID-19) outbreak, as its epicenter is shifting from China to the West.
  • COVID-19 is a top priority for Philips and all its employees.
  • I am proud that our employees around the world are stepping up to support healthcare providers and their patients in the fight against COVID-19, said Frans van Houten.
  • Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries.

Philips named a Derwent Top 100 Global Innovator for the 7th consecutive year

Retrieved on: 
Monday, February 24, 2020
Economy, Companies, Frans van Houten, Articles, Clarivate Analytics, Philips, Derwent World Patents Index, Innovation

Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has again been recognized as a Derwent Top 100 Global Innovator in Clarivate Analytics annual analysis of the global innovation ecosystem.

Key Points: 
  • Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has again been recognized as a Derwent Top 100 Global Innovator in Clarivate Analytics annual analysis of the global innovation ecosystem.
  • Philips innovation strength is powering our drive to provide integrated solutions that improve people's health across the health continuum, said Frans van Houten, CEO of Royal Philips.
  • I am pleased that we have once again been recognized, for the 7th consecutive year, as a Derwent Top 100 Global Innovator by Clarivate Analytics.
  • [1] The Derwent Top 100 Global Innovators tracks innovation based on four indicators: 1.